Ken Fisher Myriad Genetics Inc Transaction History

Fisher Asset Management, LLC

$229 Billion
Q2 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Fisher Asset Management, LLC holds 407,748 shares of MYGN stock, worth $11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

407,748

Previous 388,347 5.0%

Holding current value

$11 Million

Previous $8.28 Million 20.46%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$17.98 - $25.47 $348,829 - $494,143	19,401 Added 5.0%	407,748 $9.97 Million
Q1 2024 May 09, 2024	BUY	$17.59 - $23.59 $4.05 Million - $5.43 Million	230,378 Added 145.84%	388,347 $8.28 Million
Q4 2023 Mar 05, 2024	BUY	$13.91 - $21.32 $9,625 - $14,753	692 Added 0.44%	157,969 $3.02 Million
Q4 2023 Feb 06, 2024	BUY	$13.91 - $21.32 $203,378 - $311,719	14,621 Added 10.25%	157,277 $3.01 Million
Q3 2023 Nov 13, 2023	SELL	$15.99 - $23.22 $440,364 - $639,478	-27,540 Reduced 16.18%	142,656 $2.29 Million
Q2 2023 Dec 12, 2023	BUY	$17.56 - $23.76 $483,602 - $654,350	27,540 Added 19.31%	170,196 $3.95 Million
Q2 2023 Aug 08, 2023	SELL	$17.56 - $23.76 $377,206 - $510,388	-21,481 Reduced 11.21%	170,196 $3.95 Million
Q1 2023 Dec 12, 2023	BUY	$15.26 - $23.75 $631,275 - $982,490	41,368 Added 29.0%	184,024 $4.27 Million
Q1 2023 May 01, 2023	BUY	$15.26 - $23.75 $19,746 - $30,732	1,294 Added 0.68%	191,677 $4.45 Million
Q4 2022 Feb 03, 2023	BUY	$14.51 - $20.99 $932,644 - $1.35 Million	64,276 Added 50.97%	190,383 $2.76 Million
Q3 2022 Nov 08, 2022	BUY	$18.21 - $27.88 $987,892 - $1.51 Million	54,250 Added 75.5%	126,107 $2.41 Million
Q2 2022 Aug 09, 2022	BUY	$16.45 - $25.88 $5,395 - $8,488	328 Added 0.46%	71,857 $1.31 Million
Q1 2022 May 05, 2022	SELL	$22.67 - $28.01 $333,294 - $411,803	-14,702 Reduced 17.05%	71,529 $1.8 Million
Q4 2021 Feb 02, 2022	BUY	$24.13 - $32.63 $662,706 - $896,150	27,464 Added 46.73%	86,231 $2.38 Million
Q3 2021 Oct 26, 2021	BUY	$29.97 - $36.66 $150,239 - $183,776	5,013 Added 9.33%	58,767 $1.9 Million
Q2 2021 Jul 27, 2021	SELL	$25.39 - $32.61 $8,226 - $10,565	-324 Reduced 0.6%	53,754 $1.64 Million
Q1 2021 Apr 27, 2021	BUY	$19.92 - $31.6 $20,398 - $32,358	1,024 Added 1.93%	54,078 $1.65 Million
Q4 2020 Jan 29, 2021	BUY	$12.16 - $19.77 $39,580 - $64,351	3,255 Added 6.54%	53,054 $1.05 Million
Q3 2020 Nov 10, 2020	SELL	$11.25 - $14.75 $133,953 - $175,628	-11,907 Reduced 19.3%	49,799 $649,000
Q2 2020 Aug 07, 2020	BUY	$10.69 - $16.49 $395 - $610	37 Added 0.06%	61,706 $700,000
Q1 2020 Apr 28, 2020	BUY	$9.78 - $29.53 $176 - $531	18 Added 0.03%	61,669 $882,000
Q4 2019 Feb 12, 2020	SELL	$20.93 - $35.1 $2.5 Million - $4.19 Million	-119,504 Reduced 65.97%	61,651 $1.68 Million
Q3 2019 Oct 29, 2019	BUY	$22.08 - $47.08 $954,407 - $2.04 Million	43,225 Added 31.34%	181,155 $5.19 Million
Q2 2019 Jul 30, 2019	BUY	$22.67 - $35.0 $164,470 - $253,925	7,255 Added 5.55%	137,930 $3.83 Million
Q1 2019 Apr 22, 2019	SELL	$26.93 - $34.7 $46,777 - $60,273	-1,737 Reduced 1.31%	130,675 $4.34 Million
Q4 2018 Jan 25, 2019	BUY	$27.23 - $45.56 $112,759 - $188,663	4,141 Added 3.23%	132,412 $3.85 Million
Q3 2018 Oct 24, 2018	BUY	$37.57 - $50.34 $382,650 - $512,712	10,185 Added 8.63%	128,271 $5.9 Million
Q2 2018 Jul 09, 2018	BUY	$27.75 - $40.17 $133,116 - $192,695	4,797 Added 4.23%	118,086 $4.41 Million
Q1 2018 May 11, 2018	SELL	$28.83 - $41.01 $3.49 Million - $4.97 Million	-121,224 Reduced 51.69%	113,289 $3.35 Million
Q1 2018 Apr 19, 2018	BUY	$28.83 - $41.01 $3.29 Million - $4.68 Million	114,201 Added 94.92%	234,513 $6.93 Million
Q3 2017 Oct 17, 2017	BUY	$24.01 - $36.2 $2.89 Million - $4.36 Million	120,312	120,312 $4.35 Million

Others Institutions Holding MYGN

# of Institutions

232

Shares Held

92.6M

Call Options Held

117K

Put Options Held

113K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.18B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account